PFE · News · 20260914N

China Pipeline Acquisitions

PFIZER INC · 2026-09-14 · Importance 31 · Surprise 42

Pfizer reportedly plans selective acquisitions of early-stage assets, with particular interest in China. The initiative is intended to strengthen the pipeline as the company faces COVID-19 revenue declines and patent expiries. No transaction values, targets, regulatory jurisdictions beyond China, or closing timeframes were disclosed in the digest.

Key facts

• Pfizer is focusing on selective acquisitions in early-stage assets, particularly in China. source